Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) General Counsel Philip Mazzara sold 796 shares of the stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $291.03, for a total value of $231,659.88. Following the transaction, the general counsel owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.
Philip Mazzara also recently made the following trade(s):
- On Monday, May 18th, Philip Mazzara sold 14,076 shares of Astera Labs stock. The stock was sold at an average price of $231.78, for a total value of $3,262,535.28.
- On Wednesday, April 1st, Philip Mazzara sold 10,000 shares of Astera Labs stock. The stock was sold at an average price of $107.77, for a total value of $1,077,700.00.
- On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The stock was sold at an average price of $117.47, for a total value of $1,174,700.00.
Astera Labs Stock Performance
NASDAQ:ALAB opened at $318.72 on Wednesday. The company has a market cap of $54.63 billion, a PE ratio of 215.35, a PEG ratio of 4.06 and a beta of 3.35. Astera Labs, Inc. has a 52-week low of $84.78 and a 52-week high of $321.99. The stock has a 50-day simple moving average of $178.09 and a 200 day simple moving average of $161.43.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of ALAB. Atreides Management LP lifted its position in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Astera Labs by 14.1% in the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after buying an additional 1,693,918 shares during the last quarter. Amundi lifted its position in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC acquired a new stake in shares of Astera Labs in the third quarter valued at approximately $209,599,000. Finally, BNP Paribas Financial Markets lifted its position in shares of Astera Labs by 577.3% in the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after buying an additional 960,899 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have weighed in on ALAB. JPMorgan Chase & Co. raised their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Evercore restated an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research note on Tuesday, May 19th. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Citigroup downgraded Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday. Finally, Barclays raised their price target on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.
Get Our Latest Stock Analysis on Astera Labs
Trending Headlines about Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Astera Labs announced it will host press conferences, live demos, and technical talks at Computex 2026, where it plans to showcase its AI infrastructure connectivity portfolio, including the Scorpio X-Series 320 Lane Smart Fabric Switch, optical connectivity, and COSMOS-enabled validation tools. The event should boost visibility with analysts, customers, and ecosystem partners. Article Title
- Positive Sentiment: Recent coverage highlighted ALAB’s strong stock momentum and cited bullish analyst views, which appears to be reinforcing investor enthusiasm for the company’s AI networking and semiconductor growth story. Article Title
- Neutral Sentiment: Astera Labs was downgraded by Northland Securities from outperform to market perform, which could temper some of the recent optimism but does not by itself indicate a major deterioration in the business outlook.
- Negative Sentiment: Insider selling continues to be notable, including a large COO sale under a 10b5-1 plan and a smaller sale by the general counsel. While preplanned, heavy insider selling can weigh on sentiment because it may suggest executives are taking profits after the stock’s sharp run-up.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
